Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results

por Stefoni, V, Casadei, B, Bottelli, C, Gaidano, G, Ciochetto, C, Cabras, M G, Ansuinelli, M, Argnani, L, Broccoli, A, Gandolfi, L, Pellegrini, C, Zinzani, P L
Publicado 2016

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B

por Todeschini, G, Secchi, S, Morra, E, Vitolo, U, Orlandi, E, Pasini, F, Gallo, E, Ambrosetti, A, Tecchio, C, Tarella, C, Gabbas, A, Gallamini, A, Gargantini, L, Pizzuti, M, Fioritoni, G, Gottin, L, Rossi, G, Lazzarino, M, Menestrina, F, Paulli, M, Palestro, M, Cabras, M G, Di Vito, F, Pizzolo, G
Publicado 2004